Thrombolytic Science International is Biotechnology in United States that focus on stroke treatment business. Founded in 2004. They cover business area such as developer, biotherapeutic, heart attack, stroke treatment, clot-dissolve therapy.
2004
( 20 years old in 2024 )
Stroke Treatment
-
763D, Concord Avenue
Cambridge, MA 02138
United States
Private
developerbiotherapeuticheart attackstroke treatmentclot-dissolve therapy
* We use standard office opening hours in near Thrombolytic Science International's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Thrombolytic Science International is Biotechnology business from United States that founded in 2004 (20 years old in 2024), Thrombolytic Science International business is focusing on Stroke Treatment.
Thrombolytic Science International headquarter office and corporate office address is located in 763D, Concord Avenue Cambridge, MA 02138 United States.
Thrombolytic Science International was founded in United States.
In 2024, Thrombolytic Science International is currently focus on stroke treatment sector.
Above is snippet of Google Trends for "stroke treatment" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Thrombolytic Science International, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
